MLchartDataset catalogue

TLF

Term · Oncology and biomedicine · MLC-T-ONC-008731

A drug being studied in the treatment of kidney cancer that has spread. It is also being studied in the treatment of other types of cancer and other conditions. TLF increases the activity of dendritic cells (a type of immune cell) to help kill cancer cells. It is a form of human lactoferrin (a protein found in milk, tears, mucus, bile, and some white blood cells) that is made in the laboratory. TLF is a type of recombinant protein and a type of immunomodulatory protein. Also called talactoferrin and talactoferrin alfa.

Table 1. Record
IdentifierMLC-T-ONC-008731
FieldOncology and biomedicine
Expansionstalactoferrin; talactoferrin alfa
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008731",
  "term": "TLF",
  "field": "Oncology and biomedicine",
  "definition": "A drug being studied in the treatment of kidney cancer that has spread. It is also being studied in the treatment of other types of cancer and other conditions. TLF increases the activity of dendritic cells (a type of immune cell) to help kill cancer cells. It is a form of human lactoferrin (a protein found in milk, tears, mucus, bile, and some white blood cells) that is made in the laboratory. TLF is a type of recombinant protein and a type of immunomodulatory protein. Also called talactoferrin and talactoferrin alfa.",
  "expansions": [
    "talactoferrin",
    "talactoferrin alfa"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/tlf/"
}

Record 16,409 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.